Project Grant R56NS129122
- Grant Award Summary Texas A&M University received a $500,307 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective April 1, 2026 through February 28, 2031. The research project investigates cross-neuronal structural plasticity in Drosophila motor circuits, examining how neurons rewire and form new connections in response to nervous system...
- This federal Project Grant award of $446,126 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a new bioassay to study astrocyte borders and profile their functional states in the context of diverse non-neural cell populations. The key objectives are to optimize the bioassay by combining injectable cellulose-based hydrogels with viral vectors to...
- Federal Project Grant Award Summary Colorado State University's Sponsored Programs division received a $496,279 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 1, 2026, with a completion date of November 30, 2030. The award supports basic neuroscience research investigating cholinergic synaptic homeostasis—the compensatory mechanisms...
- This $660,000 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research at the University of Southern California (USC) on how RNA editing regulates synaptic plasticity and behavioral adaptations in the fruit fly Drosophila melanogaster. The project aims to investigate how RNA editing of glutamate-gated chloride and voltage-gated calcium channels impacts neural circuit function, synaptic plasticity, and organismal behaviors....
- Federal Project Grant Award Summary Oregon Health & Science University received a $247,702 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective December 1, 2025, through May 31, 2028. The award funds basic neuroscience research investigating the neuronal and glial mechanisms that regulate local pruning in Drosophila PAIR1 neurons, a circuit...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UCLA a Project Grant totaling $551,250 on June 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research focuses on understanding the molecular basis of synaptic specificity in the Drosophila melanogaster visual system. The project will investigate how neurons form precise synaptic connections through cell...
- Federal Grant Award Summary The Salk Institute for Biological Studies received a $355,185 Project Grant awarded August 7, 2025, by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research investigates astrocyte-neuron interactions in Rett Syndrome and Fragile X Syndrome, focusing on the role of increased astrocyte secretion of semaphorin 3C (SEMA3C) in causing...
- This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $2,357,335 to study neuronal dysfunction in Down syndrome (DS) and its link to Alzheimer's disease (AD). The key products and services delivered under this award include: Utilizing induced pluripotent stem cell (iPSC)-derived cortical organoids and assembloids to examine the cellular, transcriptomic, and motility-related...
- Yale University received a $663,942 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 25, 2025, with a completion date of June 30, 2030. The research project delivers a systematic, comprehensive investigation into the molecular mechanisms underlying synaptic exocytosis, specifically examining the interplay between complexin...
- This $274,218.64 Project Grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Brandeis University will support research into the mechanisms underlying exosome release from neurons. The grant aims to determine how exosomes are generated from the endosomal system in neurons and explore neuronal exosome and endosome biology in an animal model. The grantee will manipulate the ESCRT and MUNC13-4/RAB11 pathways to investigate endosomal dynamics...
THE ROLE OF SIALYLATION IN GLIA-NEURON COMMUNICATIONS AND STRESS RESPONSES - THE PROJECT FOCUSES ON THE MOLECULAR, CELLULAR, AND GENETIC MECHANISMS UNDERLYING THE NEURAL FUNCTIONS OF GLYCOPROTEIN SIALYLATION. ALTHOUGH THE BRAIN IS THE ORGAN WITH THE MOST PROMINENT SIALYLATION IN HUMAN BODY, AND RECENT STUDIES IMPLICATED SIALYLATION DEFECTS IN SEVERAL NEUROLOGICAL DISEASES, THE FUNCTIONS OF THIS IMPORTANT TYPE OF GLYCOSYLATION IN THE NERVOUS SYSTEM ARE STILL POORLY UNDERSTOOD. THE INTRICACIES OF GLYCOSYLATION, INCREASED PLEIOTROPY AND REDUNDANCY, AND LIMITATIONS OF AVAILABLE GENETIC APPROACHES SIGNIFICANTLY HINDER THE RESEARCH ON SIALYLATION IN THE OVERWHELMINGLY COMPLEX VERTEBRATE NERVOUS SYSTEM. A SUITABLE MODEL SYSTEM WOULD BE AN IMPORTANT TOOL FOR MORE EFFICIENT MECHANISTIC STUDIES IN THIS AREA. THE PROPOSAL FOCUSES ON DROSOPHILA AS A MODEL ORGANISM TO INVESTIGATE THE NEURAL FUNCTIONS OF N-LINKED SIALYLATION. SEVERAL KEY EVOLUTIONARILY CONSERVED ENZYMES WERE PREVIOUSLY CHARACTERIZED IN THE DROSOPHILA SIALYLATION PATHWAY, INCLUDING DSIAT, A SOLE SIALYLTRANSFERASE IN DROSOPHILA, AND CSAS, CMP-SIALIC ACID SYNTHETASE PRODUCING SUGAR DONOR FOR DSIAT. USING A COMBINATION OF IN VITRO AND IN VIVO APPROACHES, PREVIOUS STUDIES REVEALED THAT DROSOPHILA SIALYLATION IS HIGHLY REGULATED PROCESS LIMITED TO THE NERVOUS SYSTEM AND INVOLVED IN CONTROL OF NEURAL EXCITABILITY, DEVELOPMENT OF NEUROMUSCULAR JUNCTIONS (NMJS), AND THE REGULATION OF VOLTAGE-GATED CHANNELS. NOVEL FUNCTIONS OF N-LINKED SIALYLATION IN THE NERVOUS SYSTEM REGULATION SUGGESTED BY PREVIOUS RESEARCH ARE EXPECTED TO BE CONSERVED IN HUMANS AND BE RELEVANT FOR PATHOLOGIC MECHANISMS OF NEUROLOGICAL DISEASES. PRELIMINARY RESEARCH REVEALED THAT SIALYLATION IS INVOLVED IN GLIA-NEURON INTERACTIONS, AND THAT DEFECTS OF SIALYLATION RESULT IN NEURODEGENERATION AND INCREASED SENSITIVITY TO OXIDATIVE STRESS. CSAS WAS FOUND TO BE RESPONSIBLE FOR RATE-LIMITING EFFECT ON DROSOPHILA SIALYLATION, PLAYING A KEY ROLE IN NEURAL REGULATION. THE PROPOSED PROJECT WILL CAPITALIZE ON PREVIOUS AND PRELIMINARY DATA TO EXTEND RESEARCH TOWARDS (I) REVEALING SIALYLATION-MEDIATED MECHANISMS OF GLIA-NEURON COUPLING, (II) ELUCIDATING THE ROLE OF SIALYLATION IN PROMOTING NEURONAL VIABILITY AND RESISTANCE TO OXIDATIVE STRESS, (III) CHARACTERIZING FUNCTIONAL AND MOLECULAR TARGETS OF SIALYLATION USING ADVANCED CHEMICAL BIOLOGY AND GLYCOPROTEOMICS APPROACHES. THE RESEARCH PLAN IS BASED ON INTERDISCIPLINARY STRATEGY THAT COMBINES THE ADVANTAGES OF DROSOPHILA MODEL, INCLUDING AMENABILITY TO GENETIC MANIPULATIONS, EXHAUSTIVELY CHARACTERIZED NERVOUS SYSTEM, LOW REDUNDANCY OF GLYCOSYLATION PATHWAYS, AND WELL-ESTABLISHED NEUROBIOLOGICAL METHODS, WITH ADVANCED BIOCHEMICAL AND GLYCOPROTEOMIC APPROACHES. THE RESULTS WILL SHED LIGHT ON CONSERVED PRINCIPLES OF NEURAL REGULATION AND HOMEOSTASIS, WHICH WILL BE VALUABLE FOR BIOMEDICAL FEILDS. MOREOVER, THE PROJECT WILL ESTABLISH DROSOPHILA AS A VERSATILE MODEL FOR FUTURE RESEARCH ON GLYCOSYLATION IN THE NERVOUS SYSTEM TO UNCOVER PATHOLOGICAL MECHANISMS OF NEUROLOGICAL DISEASES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($3) | 5/7/26 | ||
| Not listed | $364.4k | 9/19/23 |